510(k) device
UltraShape System
Syneron Medical, Ltd. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV, Class II) · First FDA decision Oct 6, 2014, newest Nov 17, 2016Aesthetic skin, fat and body contouring
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
13
Naming "UltraShape"
MAUDE reports
5
Brand "UltraShape", since 2015
PubMed studies
9
Mentioning "UltraShape"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing UltraShape System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- UltraShape System510(k)
K162163 · Decided Nov 17, 2016 · 107 days after receipt
Device type: Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower ExtremitiesLocal determinationIn effectL36690CGS Administrators, LLCUpdated Aug 28, 2026
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
- Ultrasound, Soft Tissues of Head and NeckLocal determinationIn effectL34027First Coast Service Options, Inc.Updated Sep 18, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "UltraShape", any status and sponsor, newest update first.
Syneron MedicalNot on our public-company list
NCT03430245 · 16 participants · Start Feb 19, 2018 · Primary completion May 30, 2019
Device: VelaShape III; UltraShape Power · For: Circumference Reduction
Sites: Hackensack, New Jersey
12 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "UltraShape", and for the whole product code for context.
This brand
5 reports: 0 malfunction, 5 injury, 0 death
Whole product code OHV
185 reports: 10 malfunction, 173 injury, 0 death
Newest reports for this brand
- ULTRASHAPE POWERInjury
SYNERON MEDICAL LTD. YOKNEAM, ILLIT, ISRAEL
3003772750-2018-00002 · Received May 25, 2018 · Event dated Apr 18, 2018
Device type: Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Partial thickness (Second Degree) Burn
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "UltraShape"[tiab]. The summary above synthesizes these.
- Non-invasive, external ultrasonic lipolysis.
Coleman KM, Coleman WP, Benchetrit A · Semin Cutan Med Surg · 2009
- Body contouring by non-invasive transdermal focused ultrasound.
Moreno-Moraga J, Valero-Altés T, Riquelme AM, et al. · Lasers Surg Med · 2007Clinical Trial
- Characterization of nonthermal focused ultrasound for noninvasive selective fat cell disruption (lysis): technical and preclinical assessment.
Brown SA, Greenbaum L, Shtukmaster S, et al. · Plast Reconstr Surg · 2009
- Nonsurgical body contouring with focused ultrasound.
Hotta TA · Plast Surg Nurs · 2010
- Noninvasive body contouring by focused ultrasound: safety and efficacy of the Contour I device in a multicenter, controlled, clinical study.
Teitelbaum SA, Burns JL, Kubota J, et al. · Plast Reconstr Surg · 2007Clinical Trial, Phase II, Controlled Clinical Trial
- Clinical study to evaluate the performance of a noninvasive focused ultrasound device for thigh fat and circumference reduction compared to control.
Wilkerson EC, Bloom BS, Goldberg DJ · J Cosmet Dermatol · 2018Randomized Controlled Trial
- Safety and efficacy of UltraShape Contour I treatments to improve the appearance of body contours: multiple treatments in shorter intervals.
Ascher B · Aesthet Surg J · 2010Clinical Trial, Multicenter Study
- Ultra-Compact Low-Pass Spoof Surface Plasmon Polariton Filter Based on Interdigital Structure.
Gao ZH, Li XS, Mao M, et al. · Micromachines (Basel) · 2023
- The efficacy of a combination non-thermal focused ultrasound and radiofrequency device for noninvasive body contouring in Asians.
Shek SY, Yeung CK, Chan JC, et al. · Lasers Surg Med · 2016Clinical Trial
Other devices of this type
Also filed under product code OHV.
- Ulthera® SystemUlthera, Inc. · De Novo 2026
- SofWave SystemSofwave Medical, Ltd. · 510(k) 2024
- Ultrashape Power SystemSyneron Medical, Ltd. · 510(k) 2017
- Scizer (SC1-M410)Classys, Inc. · 510(k) 2023
- BeShape One DeviceBeshape Technologies , Ltd. · 510(k) 2023
- LIPOcelJeisys Medical, Inc. · 510(k) 2019
- Sofacia SystemSofwave Medical, Ltd. · 510(k) 2019
- Contour I V3.1 SystemSyneron Medical, Ltd. · 510(k) 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.